Compazine iv pediatric

Compazine official prescribing information for healthcare professionals. was established in 4 week clinical studies of outpatients with generalized anxiety disorder. Do not use in pediatric patients under 2 years of age or under 20 lbs COMPAZINE. 3 brand of. 4 prochlorperazine. 5 antiemetic antipsychotic tranquilizer . Do not use in pediatric patients under 2 years of age or under 20 lbs

7 Jul 2012 Prochlorperazine Edisylate (Compazine ). The authors make no claims of the accuracy of the information contained herein and these

Compazine (prochlorperazine) is effective for the short-term treatment of established in 4-week clinical studies of outpatients with generalized anxiety disorder Detailed Compazine (prochlorperazine maleate) dosage and administration Non-Psychotic Anxiety Usual dosage is 5 mg 3 or 4 times daily. COMPAZINE (prochlorperazine maleate tablets USP) should not be used in pediatric patients STUDY OBJECTIVE: We compare the effectiveness of intravenous ketorolac and intravenous prochlorperazine in the treatment of pediatric migraine headaches

Compazine - FDA prescribing information, side effects and uses

Clinical outcomes of children treated with intravenous prochlorperazine for with prochlorperazine used in children with severe migraine in a pediatric ED prochlorperazine (Rx) - Compazine, Compazine Spansules, AdultPediatric Geriatric IV: 2.5-10 mg q3-4hr not to exceed 10 mgdose or 40 mgday

25 Jun 2014 Nausea (chemotherapy): 1.8 mgkg up to 100mg IVorally x 1. Children: 0.35 mgkg (maximum: 12.5 mg) as soon as needed .. Compazine Injection may be administered either undiluted (administered over 5 to 10 minutes) 18 Dec 2014 Compazine 5-10 mg POIVIM q6-8 hours Compazine 25 mg PR q12 hours Sustained release Children (over age 2 years or gt10 kg)